Last Posted: Feb 27, 2020
- A Group-Mediated Approach to Precision Medicine-Social Identification, Prevention, and Treatment.
Beauchamp Mark R et al. JAMA psychiatry 2020 Feb - "Balancing Expectations with Actual Realities": Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial.
McGill Brittany C et al. Journal of personalized medicine 2020 Feb 10(1) - Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
Galot Rachel et al. Cancer treatment reviews 2020 Feb 85101992 - Using a single abdominal computed tomography image to differentiate five contrast-enhancement phases: A machine-learning algorithm for radiomics-based precision medicine.
Dercle Laurent et al. European journal of radiology 2020 Jan 125108850 - Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.
Emdin Connor A et al. Circulation. Genomic and precision medicine 2020 Feb (1) e002767 - Table of Pharmacogenetic Associations
FDA, February 20, 2020 - Genetic considerations for adults with congenital heart disease.
Ito Seiji et al. American journal of medical genetics. Part C, Seminars in medical genetics 2020 Feb - Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.
Nguyen-Dumont Tu et al. Familial cancer 2020 Feb - Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese Center.
Hu Wan-Ming et al. Journal of Cancer 2020 11(6) 1371-1382 - Precision medicine and actionable alterations in lung cancer: A single institution experience.
Mambetsariev Isa et al. PloS one 2020 15(2) e0228188
.png)
No hay comentarios:
Publicar un comentario